AI begins transforming precision oncology, speeding drug target discovery with AlphaFold and cutting clinical trial paperwork from months to days.
Chadi Nabhan, MD, MBA, FACP
Chadi Nabhan, MD, MBA, FACP, is a hematologist-oncologist and the chief medical officer and head of strategy at Ryght.AI.
Articles by Chadi Nabhan, MD, MBA, FACP
AI accelerates precision oncology, turning genomic data into smarter, targeted cancer treatments, fewer adverse effects, and faster decisions for personalized care.
Discover how AI accelerates precision cancer care, streamlines trials, and tackles bias and liability—what oncologists need to know now.